BeyondSpring Inc. SEC filings BYSI
BeyondSpring Inc. has 264 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Sep 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Oct 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 2, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 18, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 29, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Other events
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 21, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 23, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 16, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Other events
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 11, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Feb 25, 2025 | Feb 17, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2025 | Jan 3, 2025 |
| 6-K | Current report (foreign issuer) | Aug 29, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 6, 2024 | Aug 6, 2024 |
| 6-K | Current report (foreign issuer) | Jun 12, 2024 | Jun 12, 2024 |
| 6-K | Current report (foreign issuer) | Mar 18, 2024 | Mar 18, 2024 |
| 6-K | Current report (foreign issuer) | Feb 26, 2024 | Feb 26, 2024 |
| 6-K | Current report (foreign issuer) | Feb 2, 2024 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jan 16, 2024 | Jan 16, 2024 |
| 6-K | Current report (foreign issuer) | Jan 10, 2024 | Jan 10, 2024 |
| 6-K | Current report (foreign issuer) | Dec 18, 2023 | Dec 18, 2023 |
| 6-K | Current report (foreign issuer) | Oct 30, 2023 | Oct 30, 2023 |
| 6-K | Current report (foreign issuer) | Oct 4, 2023 | Oct 4, 2023 |
| 6-K | Current report (foreign issuer) | Sep 20, 2023 | Sep 20, 2023 |
| 6-K | Current report (foreign issuer) | Jul 14, 2023 | Jul 14, 2023 |
| 6-K | Current report (foreign issuer) | May 12, 2023 | May 12, 2023 |
| 6-K | Current report (foreign issuer) | Apr 18, 2023 | Apr 18, 2023 |
| 6-K | Current report (foreign issuer) | Mar 14, 2023 | Mar 14, 2023 |
| 6-K | Current report (foreign issuer) | Feb 28, 2023 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Feb 24, 2023 | Feb 24, 2023 |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Dec 30, 2022 | Dec 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 23, 2022 | Nov 23, 2022 |
| 6-K | Current report (foreign issuer) | Aug 29, 2022 | Aug 29, 2022 |
| 6-K | Current report (foreign issuer) | Jun 13, 2022 | Jun 13, 2022 |
| 6-K | Current report (foreign issuer) | Jun 9, 2022 | Jun 9, 2022 |
| 6-K | Current report (foreign issuer) | Apr 22, 2022 | Apr 22, 2022 |
| 6-K | Current report (foreign issuer) | Jan 11, 2022 | Jan 11, 2022 |
| 6-K | Current report (foreign issuer) | Dec 30, 2021 | Sep 30, 2021 |
| 6-K | Current report (foreign issuer) | Dec 27, 2021 | Dec 24, 2021 |
| 6-K | Current report (foreign issuer) | Dec 1, 2021 | Dec 1, 2021 |
| 6-K | Current report (foreign issuer) | Nov 10, 2021 | Nov 10, 2021 |
| 6-K | Current report (foreign issuer) | Sep 21, 2021 | Sep 20, 2021 |
| 6-K | Current report (foreign issuer) | Sep 10, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Aug 26, 2021 | Aug 26, 2021 |
| 6-K | Current report (foreign issuer) | Aug 5, 2021 | Aug 5, 2021 |
| 6-K | Current report (foreign issuer) | Aug 4, 2021 | Aug 4, 2021 |
| 6-K | Current report (foreign issuer) | Jul 14, 2021 | Jul 14, 2021 |
| 6-K | Current report (foreign issuer) | Jun 16, 2021 | Mar 31, 2021 |
| 6-K | Current report (foreign issuer) | Apr 1, 2021 | Apr 1, 2021 |
| 6-K/A | Filing | Mar 29, 2021 | Mar 29, 2021 |
| 6-K | Current report (foreign issuer) | Mar 19, 2021 | Mar 19, 2021 |
| 6-K | Current report (foreign issuer) | Mar 16, 2021 | Mar 16, 2021 |
| 6-K | Current report (foreign issuer) | Feb 9, 2021 | Feb 9, 2021 |
| 6-K | Current report (foreign issuer) | Dec 18, 2020 | Dec 18, 2020 |
| 6-K | Current report (foreign issuer) | Nov 23, 2020 | Nov 23, 2020 |
| 6-K | Current report (foreign issuer) | Nov 17, 2020 | Sep 30, 2020 |
| 6-K | Current report (foreign issuer) | Nov 16, 2020 | Nov 16, 2020 |
| 6-K | Current report (foreign issuer) | Nov 13, 2020 | Nov 13, 2020 |
| 6-K | Current report (foreign issuer) | Sep 22, 2020 | Sep 22, 2020 |
| 6-K | Current report (foreign issuer) | Sep 3, 2020 | Jun 30, 2020 |
| 6-K | Current report (foreign issuer) | Aug 19, 2020 | Aug 19, 2020 |
| 6-K | Current report (foreign issuer) | Jul 24, 2020 | Jul 24, 2020 |
| 6-K | Current report (foreign issuer) | Jun 23, 2020 | Jun 23, 2020 |
| 6-K | Current report (foreign issuer) | Jun 15, 2020 | Jun 15, 2020 |
| 6-K | Current report (foreign issuer) | Jun 11, 2020 | Mar 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 11, 2020 | Mar 11, 2020 |
| 6-K | Current report (foreign issuer) | Feb 7, 2020 | Feb 7, 2020 |
| 6-K | Current report (foreign issuer) | Jan 23, 2020 | Jan 23, 2020 |
| 6-K | Current report (foreign issuer) | Dec 18, 2019 | Sep 30, 2019 |
| 6-K | Current report (foreign issuer) | Oct 29, 2019 | Oct 29, 2019 |
| 6-K | Current report (foreign issuer) | Sep 18, 2019 | Jun 30, 2019 |
| 6-K | Current report (foreign issuer) | Jul 19, 2019 | Jul 19, 2019 |
| 6-K | Current report (foreign issuer) | Jul 10, 2019 | Jul 10, 2019 |
| 6-K | Current report (foreign issuer) | Jul 10, 2019 | Mar 31, 2019 |
| 6-K | Current report (foreign issuer) | May 22, 2019 | May 22, 2019 |
| 6-K | Current report (foreign issuer) | Oct 23, 2018 | Oct 23, 2018 |
| 6-K | Current report (foreign issuer) | Oct 23, 2018 | Oct 23, 2018 |
| 6-K | Current report (foreign issuer) | Aug 1, 2018 | Aug 1, 2018 |
| 6-K | Current report (foreign issuer) | Jun 21, 2018 | Jun 21, 2018 |
| 6-K | Current report (foreign issuer) | May 30, 2018 | May 30, 2018 |
| 6-K | Current report (foreign issuer) | Mar 27, 2018 | Mar 27, 2018 |
| 6-K | Current report (foreign issuer) | Feb 21, 2018 | Feb 21, 2018 |
| 6-K | Current report (foreign issuer) | Jan 29, 2018 | Jan 29, 2018 |
| 6-K | Current report (foreign issuer) | Nov 9, 2017 | Nov 9, 2017 |
| 6-K | Current report (foreign issuer) | Aug 21, 2017 | Aug 21, 2017 |
| 6-K | Current report (foreign issuer) | May 24, 2017 | May 24, 2017 |
| 6-K | Current report (foreign issuer) | May 22, 2017 | May 22, 2017 |
| 6-K | Current report (foreign issuer) | May 4, 2017 | May 2, 2017 |
Showing 100 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BYSI (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1677940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.